The results showed that age, CVC, CRP, fibrinogen, D-dimer, vWF, FVIII, and treatment regimen immunomodulator (IMiD) were potential influencing factors for VTE in MM patients (see Table 1). This evidence concerns the gene F8 and Miyoshi myopathy.